What’s the Latest? Psychedelics for Opioid Use Disorder

Sponsored by UW ADAI's Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER), State Opioid Response (SOR) team.

What does the emerging research indicate about the role of psychedelics in treating opioid use disorder (OUD)? In this session, we’ll explore the current evidence, potential mechanisms, safety considerations, and the possible future of psychedelic treatment approaches in OUD care. 

Speaker: Nathan Sackett, MD, MS, Director, Center for Novel Therapeutics in Addiction Psychiatry at the University of Washington School of Medicine